Abstract

Insights

Oxymatrine (OMT) demonstrates analgesic effects on neuropathic pain by modulating high voltage-dependent calcium channels (HVDCCs). This treatment also influences gamma-aminobutyric acid (GABA) release, suggesting a potential therapeutic mechanism.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Neuropathic pain is a debilitating condition often associated with altered neuronal excitability.
  • High voltage-dependent calcium channels (HVDCCs) play a crucial role in neuronal signaling and pain transmission.
  • GABAergic system dysfunction is implicated in the pathophysiology of neuropathic pain.

Purpose of the Study:

  • To investigate the analgesic effects of oxymatrine (OMT) in a mouse model of neuropathic pain.
  • To explore the impact of OMT on HVDCCs expression in the brain and spinal cord.
  • To examine the influence of OMT on GABA release in the central nervous system.

Main Methods:

  • Establishment of a neuropathic pain model in C57BL/6 mice using partial sciatic nerve ligation (PSNL).
  • Assessment of mechanical withdrawal threshold (MWT) using the Von-Frey filament test.
  • Quantification of HVDCCs mRNA expression via Real-time PCR and GABA concentration using ELISA.

Main Results:

  • PSNL induced significant mechanical allodynia, which was reversed by OMT administration.
  • OMT modulated the mRNA expression of various HVDCC subtypes (Cav1.2, Cav1.3, Cav2.1, Cav2.3, Cav2.2) in both brain and spinal cord tissues.
  • OMT treatment increased GABA levels in brain tissues, while spinal cord GABA levels remained unchanged.

Conclusions:

  • Oxymatrine exhibits significant analgesic effects in a mouse model of neuropathic pain.
  • The therapeutic action of OMT is likely mediated through the modulation of HVDCCs.
  • Cav2.2 may play a direct role in regulating GABA release, contributing to OMT's analgesic properties.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.9K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K